Neurocrine Biosciences (NBIX) Receivables - Net: 2010-2020
Historic Receivables - Net for Neurocrine Biosciences (NBIX) over the last 8 years, with Dec 2020 value amounting to $157.1 million.
- Neurocrine Biosciences' Receivables - Net rose 4.40% to $163.8 million in Q3 2021 from the same period last year, while for Sep 2021 it was $163.8 million, marking a year-over-year increase of 4.40%. This contributed to the annual value of $157.1 million for FY2020, which is 24.09% up from last year.
- According to the latest figures from FY2020, Neurocrine Biosciences' Receivables - Net is $157.1 million, which was up 24.09% from $126.6 million recorded in FY2019.
- Neurocrine Biosciences' Receivables - Net's 5-year high stood at $157.1 million during FY2020, with a 5-year trough of $31.1 million in FY2017.
- Moreover, its 3-year median value for Receivables - Net was $126.6 million (2019), whereas its average is $113.7 million.
- Data for Neurocrine Biosciences' Receivables - Net shows a peak YoY surged of 120.53% (in 2019) over the last 5 years.
- Yearly analysis of 4 years shows Neurocrine Biosciences' Receivables - Net stood at $31.1 million in 2017, then skyrocketed by 84.43% to $57.4 million in 2018, then soared by 120.53% to $126.6 million in 2019, then climbed by 24.09% to $157.1 million in 2020.